TLGT.Q Stock Overview
Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Teligent, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.63 |
| 52 Week Low | US$0.0001 |
| Beta | 1.21 |
| 1 Month Change | 0% |
| 3 Month Change | -80.00% |
| 1 Year Change | -99.96% |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Shareholder Returns
| TLGT.Q | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 0.08% | 1.2% |
| 1Y | -100.0% | 13.2% | 24.9% |
Return vs Industry: TLGT.Q underperformed the US Pharmaceuticals industry which returned -4.4% over the past year.
Return vs Market: TLGT.Q underperformed the US Market which returned 15.2% over the past year.
Price Volatility
| TLGT.Q volatility | |
|---|---|
| TLGT.Q Average Weekly Movement | 884.8% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TLGT.Q's share price has been volatile over the past 3 months.
Volatility Over Time: TLGT.Q's weekly volatility has increased from 438% to 885% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | 146 | n/a | www.teligent.com |
Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets.
Teligent, Inc. Fundamentals Summary
| TLGT.Q fundamental statistics | |
|---|---|
| Market cap | US$18.56k |
| Earnings (TTM) | -US$91.57m |
| Revenue (TTM) | US$46.30m |
0.0x
P/S Ratio0.0x
P/E RatioIs TLGT.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TLGT.Q income statement (TTM) | |
|---|---|
| Revenue | US$46.30m |
| Cost of Revenue | US$55.28m |
| Gross Profit | -US$8.98m |
| Other Expenses | US$82.58m |
| Earnings | -US$91.57m |
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.99 |
| Gross Margin | -19.41% |
| Net Profit Margin | -197.78% |
| Debt/Equity Ratio | -267.7% |
How did TLGT.Q perform over the long term?
See historical performance and comparison